Our team at BASi Research Products and our partners at Inotiv are monitoring the COVID-19 pandemic and reviewing our business continuity plans daily. We have assembled a risk management team that is keeping abreast of updated guidance from the Centers for Disease Control and Prevention (CDC), the World Health Organization (WHO), and state and local authorities.
At this time, our production is fully operational and we have not identified any issues related to logistics, supplies, or other resources, that will affect our ability to continue supporting our clients. This is true for both the products and the contract research services components of our business.
During this challenging period, we would like to reassure you that BASi remains open for business and committed to business continuity and helping you achieve your research goals. Please also know that we are prioritizing the safety and well-being of our employees and their families and we are also taking steps to minimize impact to our clients’ health and safety.
While this situation is continuously evolving, we have taken several proactive steps, including:
We are experiencing some disruptions to our service and training visits, and we will work with each affected company to come to a resolution that meets the needs of both sides, while accounting for the safety and well-being of staff and clients.
To all of our valued clients, we are committed to our mission of creating research products that get you better data so that you can make better decisions. We remain committed to that mission during these critical and unprecedented times.